Toxicologie > Valeurs de référence > Autres valeurs des organismes reconnus
Last update the 06/06/2017| Target | Exposure route | Effect type | Exposure type | Value name | Value | Source | Commentary | Critical effect retained | Status state | Exposure duration | Environment | Exposure source | Factor | Management context | Age dependent adjustments factors | ADAF - Age range | ADAF - Value | ADAF - URL |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Population générale | Orale | A seuil | Chronique | TDI | 0,00036 mg.kg-1.j-1 | EFSA (2011) | Cadmium et ses composés | ?2-microglobinurie | Final | Eau | ||||||||
| Population générale | Orale | A seuil | Chronique | MRL | 0,0001 mg.kg-1.j-1 | ATSDR (2012) | Renal | Final | Eau | |||||||||
| Population générale | Orale | A seuil | Chronique | RfD | 0,001 mg.kg-1.j-1 | US EPA (1989) | Food | Significant proteinuria | Final | Eau | ||||||||
| Population générale | Orale | A seuil | Chronique | RfD | 0,0005 mg.kg-1.j-1 | US EPA (1989) | Water | Significant proteinuria | Final | Eau | ||||||||
| Population générale | Orale | A seuil | Chronique | TDI | 0,5 µg.kg-1.j-1 | RIVM (2001) | Final | Eau | ||||||||||
| Population générale | Orale | A seuil | Chronique | DJT provisoire | 0,0008 mg.kg-1.j-1 | Sante Canada (2025) | Néphrotoxicité (dysfonctionnement des tubules rénaux) | Provisoire | Eau | |||||||||
| Population générale | Orale | A seuil | Chronique | PTMI | 25 µg.kg-1 | OMS (2022) | soit 0,83 µg.kg-1.j-1 | ?2-microglobulin excretion in urine | Provisoire | Eau | ||||||||
| Population générale | Orale | A seuil | Chronique | REL | 0,5 µg.kg-1.j-1 | OEHHA (2000) | Kidney effects (proteinuria) and respiratory effects (reduction in forced vital capacity and reduction in peak expiratory flow rate) in occupationally exposed humans | Final | Eau | |||||||||
| Population générale | Orale | A seuil | Chronique | PTMI | 25 µg.kg-1.mois-1 | OMS JECFA (2010) | soit 0,8 µg.kg-1.j-1 | Provisoire | Eau | |||||||||
| Population générale | Inhalation | A seuil | Chronique | MRL | 0,00001 mg.m-3 | ATSDR (2012) | Renal | Final | Air ambiant | |||||||||
| Population générale | Inhalation | A seuil | Chronique | REL | 0,02 µg.m-3 | OEHHA (2002) | Kidney effects (proteinuria) and respiratory effects (reduction in forced vital capacity and reduction in peak expiratory flow rate) in occupationally exposed humans | Final | Air ambiant | |||||||||
| Population générale | Inhalation | Sans seuil | Chronique | Inhalation Unit Risk | 0,0018 (µg.m-3)-1 | US EPA (1987) | Lung, trachea, bronchus cancer deaths | Final | Air ambiant | |||||||||
| Population générale | Inhalation | Sans seuil | Chronique | CERUi | 4,2 (mg.m-3)-1 | Sante Canada (2025) | cancer du poumon | Final | Air ambiant | |||||||||
| Population générale | Inhalation | Sans seuil | Chronique | Inhalation Unit Risk | 0,0042 (µg.m-3)-1 | OEHHA (2011) | lung cancer | Final | Air ambiant |